This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Crispr Therapeutics Ag. Active years: 2022-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2023
Title: Troy Dean Carlo: Innovator in Genomic Editing
Introduction
Troy Dean Carlo is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of genomic editing, particularly in the context of treating genetic disorders. With a total of 2 patents, his work focuses on innovative methods for correcting genetic mutations.
Latest Patents
Troy Dean Carlo's latest patents include compositions and methods for genomic editing by the insertion of donor polynucleotides. These patents provide donor polynucleotides, genome editing systems, methods, pharmaceutical compositions, and kits that correct or induce a mutation causing Glycogen Storage Disease 1a in a genomic DNA molecule within a cell. In some embodiments, the disclosure provides donor polynucleotides comprising two strands capable of correcting this specific mutation.
Career Highlights
Troy Dean Carlo is associated with Crispr Therapeutics AG, a company at the forefront of gene editing technology. His work at Crispr Therapeutics AG has positioned him as a key player in the development of innovative solutions for genetic disorders.
Collaborations
Troy collaborates with Roman Lvovitch Bogorad, contributing to advancements in genomic research and therapies.
Conclusion
Troy Dean Carlo's innovative work in genomic editing showcases his commitment to addressing genetic disorders through advanced technologies. His contributions are paving the way for future breakthroughs in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile